Royal Bank of Canada’s Entera Bio ENTX Stock Holding History

Royal Bank of Canada’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,000	Closed	-$5K	–	7177
2024 Q1	$5K	Buy	3,000 +2,800	+1,400%	+$3.09K	﹤0.01%	6429
2023 Q4	$0	Buy	+200	New	+$136	﹤0.01%	7240
2023 Q3	–	Sell	-576	Closed	–	–	7203
2023 Q2	$0	Hold	576	–	–	﹤0.01%	7358
2023 Q1	$1K	Hold	576	–	–	﹤0.01%	6880
2022 Q4	$0	Hold	576	–	–	﹤0.01%	7346
2022 Q3	$1K	Hold	576	–	–	﹤0.01%	7175
2022 Q2	$1K	Sell	576 -5	-0.9%	-$11	﹤0.01%	7110
2022 Q1	$2K	Buy	+581	New	+$1.39K	﹤0.01%	7473
2021 Q4	–	Sell	-1,894	Closed	-$9K	–	7719
2021 Q3	$9K	Buy	+1,894	New	+$9.71K	﹤0.01%	6997

Other funds holding ENTX

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Royal Bank of Canada's ENTX Position: Q2 2024 in Review

Royal Bank of Canada sold out of Entera Bio (ENTX) in Q2 2024, closing a stake of 3,000 shares — an estimated $5K sold.

Royal Bank of Canada first reported a position in ENTX in Q3 2021 and held it in 9 quarters. The position peaked at $9K in Q3 2021. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2024.

Royal Bank of Canada reported no remaining Entera Bio position as of Q2 2024 after selling out during the quarter.
Royal Bank of Canada sold 3,000 Entera Bio shares in Q2 2024, an estimated $5K.
Royal Bank of Canada first reported a position in Entera Bio in Q3 2021 and held it in 9 quarters.
Royal Bank of Canada's Entera Bio position peaked at $9K in Q3 2021.
15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2024.

Based on Royal Bank of Canada's 13F filing for Q2 2024, filed 14 Aug 2024.